Unternehmen
SEREND-IP GMBH
SEREND-IP GMBH – Unternehmen mit Aktivitäten in Forschung und Innovation.
Forschungsprojekte
- Heparanase inhibition as a multifunctional targeting approach in cancer Cancer is a leading cause of mortality within the aging European population. Therapeutic targeting is hampere…
- Human ECM-based platform for anti-cancer drug testing - CARES (CAncer dRug tESting) With 2 million cancer-related deaths and an annual cost of €100 billion, cancer constitutes a major European…